Xeloda Black Box Warning Added Due toBleeding Risk with Blood Thinner Use
The FDA has added a new black box warning to Xeloda, a cancer drug which may increase the risk of bleeding when used with certain blood thinners.
The FDA has added a new black box warning to Xeloda, a cancer drug which may increase the risk of bleeding when used with certain blood thinners.
Canadian officials warn that the cancer drug Xeloda is associated with fatal but rare skin reactions.
In 2012, there was an increase in FDA adverse event reports involving patient deaths linked to drug side effects, and a number of drugs racked up large amounts of adverse…